Targeted therapy shows benefit for people with advanced breast cancer in late-stage trial
By Jen Christensen, CNN An experimental treatment shows promise for people with the most common form of advanced-stage breast cancer, according to results from a Phase 3 clinical trial. The details of the trial were presented Thursday at the San Antonio Breast Cancer Symposium. It showed that AstraZeneca’s capivasertib — in combination with Faslodex (fulvestrant),
Continue Reading